Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic Ingenol Mebutate vs Picato in Actinic Keratosis
NCT02654769Phase 3Completed
- Sponsor
- Allergan
- Start
- Feb 2015
- Primary completion
- Sep 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ingenol mebutate in actinic keratosis (AK), sponsored by Allergan. Started Feb 2015; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02654769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02654769.